<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05117086</url>
  </required_header>
  <id_info>
    <org_study_id>1770356</org_study_id>
    <nct_id>NCT05117086</nct_id>
  </id_info>
  <brief_title>DASH Diet in Heart Failure Outpatients</brief_title>
  <acronym>DASH-HF</acronym>
  <official_title>DASH Diet in Heart Failure Pilot Study - Integration and Effectiveness of Medical Nutrition Therapy Counseling on DASH Diet in the Management of Heart Failure Patients in an Academic Outpatient Cardiology Clinic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American College of Cardiology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to refine the classification of the effectiveness of the DASH&#xD;
      diet for outpatient heart failure (HF) management, using behavioral, clinical, and laboratory&#xD;
      correlative science approaches.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall objective of this pilot study is to refine the classification of the&#xD;
      effectiveness of the DASH diet for outpatient HF management using behavioral, clinical, and&#xD;
      laboratory correlative science approaches. The investigators will integrate the use and&#xD;
      evaluation of DASH diet nutrition education in a clinical population using a pragmatic study&#xD;
      approach. The investigators will assess dietary behavior change. The investigators will&#xD;
      assess the medical effectiveness of the DASH diet to improve patient symptomology and&#xD;
      clinical biomarkers. Exploratory investigations will involve metabolomics analyses of plasma&#xD;
      samples for biomarker discovery of clinical phenotypes in HF patients, to characterize&#xD;
      metabolic profiles related to dietary exposure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">April 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single arm pragmatic trial with pre- and post- assessments</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dietary intake</measure>
    <time_frame>Dietary intake at baseline</time_frame>
    <description>Dietary intake assessed by nutrient analysis of food records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dietary intake</measure>
    <time_frame>Dietary intake at 3 months</time_frame>
    <description>Dietary intake assessed by nutrient analysis of food records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dietary intake</measure>
    <time_frame>Dietary intake at 6 months</time_frame>
    <description>Dietary intake assessed by nutrient analysis of food records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diet score</measure>
    <time_frame>Dietary intake at baseline</time_frame>
    <description>Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score). Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diet score</measure>
    <time_frame>Dietary intake at 3 months</time_frame>
    <description>Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score). Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diet score</measure>
    <time_frame>Dietary intake at 6 months</time_frame>
    <description>Dietary intake assessed by calculation of DASH diet score (Dietary Approaches to Stop Hypertension diet score). Minimum to Maximum values: 8-40 Higher scores mean better outcome and diet composition.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Systolic and diastolic Blood Pressure at baseline</time_frame>
    <description>Blood Pressure assessed with systolic and diastolic pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Systolic and diastolic Blood Pressure at 3 months</time_frame>
    <description>Blood Pressure assessed with systolic and diastolic pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Systolic and diastolic Blood Pressure at 6 months</time_frame>
    <description>Blood Pressure assessed with systolic and diastolic pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart Failure clinical marker</measure>
    <time_frame>proBNP at baseline</time_frame>
    <description>proBNP will be assessed as a marker of severity of heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Failure clinical marker</measure>
    <time_frame>proBNP at 3 months</time_frame>
    <description>proBNP will be assessed as a marker of severity of heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Failure clinical marker</measure>
    <time_frame>proBNP at 6 months</time_frame>
    <description>proBNP will be assessed as a marker of severity of heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient report of HF symptoms</measure>
    <time_frame>KCCQ at baseline</time_frame>
    <description>Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms. Minimum to Maximum values: 0-100. Higher scores represent better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient report of HF symptoms</measure>
    <time_frame>KCCQ at 3 months</time_frame>
    <description>Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms. Minimum to Maximum values: 0-100. Higher scores represent better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient report of HF symptoms</measure>
    <time_frame>KCCQ at 6 months</time_frame>
    <description>Kansas City Cardiomyopathy Questionnaire (KCCQ) will assess patient report of symptoms. Minimum to Maximum values: 0-100. Higher scores represent better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient report of eating habit self efficacy</measure>
    <time_frame>Eating Habits at Baseline</time_frame>
    <description>Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits. Minimum to Maximum values:27-135. Higher value is better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient report of eating habit self efficacy</measure>
    <time_frame>Eating Habits at 3 months</time_frame>
    <description>Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits. Minimum to Maximum values:27-135. Higher value is better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient report of eating habit self efficacy</measure>
    <time_frame>Eating Habits at 6 months</time_frame>
    <description>Eating Habits Questionnaire will assess patient report of self efficacy for behavior change around DASH diet eating habits. Minimum to Maximum values:27-135. Higher value is better outcome.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Dietary Intervention Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive the active intervention of nutrition education and medical nutrition therapy counseling for dietary and behavioral lifestyle changes. The focus will be on DASH diet implementation and adherence for management of heart failure. The subjects will have 4 study visits with a Registered Dietitian over 6 months (visits at 1, 2, 3, and 6 months). Outcome measures will be assessed at baseline, 3 and 6 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>DASH diet</intervention_name>
    <description>Nutrition education and counseling on DASH diet, behavioral and lifestyle modifications</description>
    <arm_group_label>Dietary Intervention Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Heart Failure diagnosis&#xD;
&#xD;
          -  Guideline directed medical therapy optimization on stable regimen at least 30 days&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI &lt; 18/5 kg/m squared&#xD;
&#xD;
          -  cardiac cachexia&#xD;
&#xD;
          -  end-stage renal disease or dialysis&#xD;
&#xD;
          -  acute inflammatory condition&#xD;
&#xD;
          -  uncontrolled arrhythmias or ischemia&#xD;
&#xD;
          -  status post heart transplant or implanted left ventricular assist device&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francene Steinberg, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francene Steinberg, PhD</last_name>
    <phone>530 752 0160</phone>
    <email>fmsteinberg@ucdavis.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brooke Wickman, MS</last_name>
    <email>bewickman@ucdavis.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ragle Human Nutrition Center</name>
      <address>
        <city>Davis</city>
        <state>California</state>
        <zip>95616</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 1, 2021</study_first_submitted>
  <study_first_submitted_qc>November 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 11, 2021</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

